- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06555172
Feasibility Testing a Meditation App for Professionals Working With Youth in the Legal System
May 4, 2026 updated by: Ashley D Kendall, University of Illinois at Chicago
Feasibility Trial of a Mindfulness-based mHealth Intervention to Mitigate the Effects of Chronic Workplace Stress Among Juvenile Justice Officers
This feasibility clinical trial aims to assess the feasibility of implementing a 1-month app-based meditation program with officers in the juvenile legal system and other professionals working directly with legal-involved youth.
Study Overview
Status
Active, not recruiting
Conditions
Intervention / Treatment
Detailed Description
Professionals working with legal-involved youth experience high levels of depression, anxiety, and workplace burnout.
Mindfulness meditation targets emotion regulation-which appears to be a common mechanism underlying depression, anxiety, and burnout-and it can be effectively delivered via smartphone app.
This project will assess the feasibility of implementing a 1-month app-based meditation program with officers and other professionals working with legal-involved youth.
The findings are intended to inform the development of a future, fully-powered hybrid effectiveness-implementation randomized controlled trial (RCT).
Study Type
Interventional
Enrollment (Actual)
57
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Illinois
-
Chicago, Illinois, United States, 60612
- University of Illinois Chicago
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Currently working with youth in the juvenile legal system or related juvenile services and programming
- English speaking
- Able to understand and provide consent
- At least 18 years old
- Have an Android or Apple smartphone
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Action In Mindfulness (AIM)+
Participants randomized to the intervention arm will receive the AIM+ mindfulness meditation app.
|
AIM+ is a smartphone-based app that teaches mindfulness meditation to professionals working with legal-involved youth over a 30-day "path."
Each day of the path consists of a brief (approximately 5- to 10-minute) audio-guided meditation practice, with brief videos interspersed to illustrate key concepts and promote engagement.
In addition to the 30 daily path files, users have access to a menu of "to go" audio-guided meditation practices that they can use as relevant to their workday (e.g., for professionals to listen to before attending a meeting).
AIM+ also includes a menu of audio-guided meditation practices that officers can share with the youth on their caseloads (e.g., for youth to listen to before attending court).
|
|
Active Comparator: Resource+
Participants randomized to the active control arm will receive the Resource+ smartphone-based program.
|
Resource+ is a 30-day smartphone-based program that includes information on local and national resources that professionals can use to learn about organizations and services available to youth with whom they work.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
App adherence
Time Frame: 1 month
|
Days of objective app usage
|
1 month
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Acceptability
Time Frame: 1 month
|
Measured by Acceptability of Intervention Measure (AIM).
This scale measures acceptability using 4 items, each item rated on a 5-point scale and averaged to yield total scale scores between 1 and 5; higher scores indicate greater acceptability.
|
1 month
|
|
Appropriateness
Time Frame: 1 Month
|
Measured with the Intervention Appropriateness Measure (IAM).
This scale measures appropriateness using 4 items, each item rated on a 5-point scale and averaged to yield total scale scores between 1 and 5; higher scores indicate greater appropriateness.
|
1 Month
|
|
Feasibility of App Implementation
Time Frame: 1 month
|
Measured with the Feasibility of Intervention Measure (FIM).
This scale measures feasibility using 4 items, each item rated on a 5-point scale and averaged to yield total scale scores between 1 and 5; higher scores indicate greater feasibility.
|
1 month
|
|
Usability
Time Frame: 1 month
|
Measured with the System Usability Scale (SUS).
This scale measures the usability of products and designs, specifically effectiveness, efficiency, and user satisfaction using 10 items, each item is rated on a 5-point scale; items calculated to produce a total score between 0 and 100; higher scores generally indicate greater usability.
|
1 month
|
|
Satisfaction with intervention
Time Frame: 1 month
|
Measured with the Client Satisfaction Questionnaire (CSQ-8).
This scale measures satisfaction using 8 items, each item is rated on a 4-point scale; total sum scores range from 8 to 32; higher scores indicate higher satisfaction.
|
1 month
|
|
Penetration
Time Frame: 1 and 6 month
|
Measured via objective app analytics.
|
1 and 6 month
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Anxiety
Time Frame: baseline, 1 month, 6 months
|
Measured with the PROMIS Anxiety scale.
This scale measures anxiety symptoms over the past week using a computer adaptive test/item bank administers of to 12 items, each rated on a 5-point scale; integrated adaptive scoring yields a T-score and standard error (SE); higher scores indicating more anxiety symptoms.
|
baseline, 1 month, 6 months
|
|
Depression
Time Frame: baseline, 1 month, 6 months
|
Measured with the PROMIS Depression Scale.
This scale measures depression symptoms over the past week using a computer adaptive test/item bank administers of to 12 items, each rated on a 5-point scale; integrated adaptive scoring yields a T-score and standard error (SE); higher scores indicating more depression symptoms.
|
baseline, 1 month, 6 months
|
|
Workplace burnout
Time Frame: baseline, 1 month, 6 months
|
Measured with the Maslach Burnout Inventory General (MBI-G). This measure contains three scales measuring emotional exhaustion, depersonalization, and personal accomplishment.
|
baseline, 1 month, 6 months
|
|
Perceived stress
Time Frame: baseline, 1 month, 6 months
|
Measured with the Perceived Stress Scale.
This scale measures perception of stress over the past month, i.e. the degree to which situations in one's life are appraised as stressful, using 10-items each rated on a 5-point scale; total sum scores range from 0-40, with higher scores indicate more perceived stress.
|
baseline, 1 month, 6 months
|
|
Anger
Time Frame: baseline, 1 month, 6 months
|
Measured with the PROMIS Short Form v1.1 Anger 5a scale.
This scale measures anger over the past 7 days using 5 items, each item rated on a 5-point scale; integrated scoring yields a T-score and standard error (SE), with higher scores indicating more anger.
|
baseline, 1 month, 6 months
|
|
Sleep disturbance
Time Frame: baseline, 1 month, 6 months
|
Measured with the PROMIS Short Form v1.0 Sleep Disturbance.
This scale measures sleep disturbance over the past 7 days using 8 items, each item rated on a 5-point scale; integrated scoring yields a T-score and standard error (SE); higher scores indicate more sleep disturbance.
|
baseline, 1 month, 6 months
|
|
Alcohol use
Time Frame: baseline, 1 month, 6 months
|
Measured with the PROMIS Short Form v1.0 Alcohol Use 7a.
This scale measures alcohol consumption, cravings, or difficulty controlling drinking over the past 30 days using 7 items, each item rated on a 5-point scale; integrated scoring yields a T-score and standard error (SE); higher scores indicate more alcohol consumption, cravings, or difficulty controlling drinking.
|
baseline, 1 month, 6 months
|
|
Mindfulness
Time Frame: baseline, 1 month, 6 months
|
Measured with the Five Facets of Mindfulness Questionnaire (FFMQ-15).
This scale measures mindfulness with subscales for observing, describing, acting with awareness, non-judging, and non-reactivity using 15 items, each item rated on a 5-point scale; total sum scores range from 15-75; higher scores indicate higher levels of mindfulness.
|
baseline, 1 month, 6 months
|
|
Regulation of negative mood states
Time Frame: baseline, 1 month, 6 months
|
Measured with the Negative Mood Regulation (NMR) Scale.
This scale measures regulation of negative mood states using 14 items, each item rated on a 5-point scale; averaged to yield total scale scores between 1 and 5; higher scores indicate a strong belief that one can alter negative moods.
|
baseline, 1 month, 6 months
|
|
Resilience
Time Frame: baseline, 1 month, 6 months
|
Measured with the Brief Resilience Scale.
This scale measures resilience, i.e. adaptation, thriving, and resistance to illness using 6 items, each item rated on a 5-point scale; averaged to yield total scale scores between 1 and 5; higher scores indicate more resilience.
|
baseline, 1 month, 6 months
|
|
Attentional control
Time Frame: baseline, 1 month, 6 months
|
Measured with the Attention Control Scale (ATTC).
This scale measures two major components of attention (attention focusing and attention shifting) and consists of 20 items that are rated on a four-point Likert scale from 1 (almost never) to 4 (always); some items are reverse coded and scale scores are calculated as the sum of respective items; higher scores indicate greater attention control.
|
baseline, 1 month, 6 months
|
|
Current positive and negative mood states
Time Frame: baseline, 1 month
|
Measured with the International Positive Affect Negative Affect Schedule Short Form (I-PANAS-SF).
This scale measures positive and negative affect, with subscales for positive and negative affect, using 10 items, each item rated on a 5-point scale; sum scores range from 5 to 25; higher scores indicate greater tendency to experiences positive or negative mood, respectively.
|
baseline, 1 month
|
|
Current attentional control
Time Frame: baseline, 1 month
|
Measured using 2 items asking about trouble focusing and distraction in the past 3 hours, rated on a scale of 1 (never) to 6 (almost always); items are reverse-coded and averaged to form a composite representing momentary attentional control; higher scores indicate greater attentional control.
|
baseline, 1 month
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 21, 2024
Primary Completion (Estimated)
July 1, 2026
Study Completion (Estimated)
January 1, 2027
Study Registration Dates
First Submitted
August 12, 2024
First Submitted That Met QC Criteria
August 12, 2024
First Posted (Actual)
August 15, 2024
Study Record Updates
Last Update Posted (Actual)
May 7, 2026
Last Update Submitted That Met QC Criteria
May 4, 2026
Last Verified
May 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Occupational Stress
- Burnout, Psychological
- Mental Disorders
- Behavioral Symptoms
- Stress, Psychological
- Occupational Diseases
- Behavior
- Social Behavior
- Self-Control
- Anxiety Disorders
- Depression
- Burnout, Professional
- Emotional Regulation
- Delivery of Health Care
- Health Care Quality, Access, and Evaluation
- Behavior Therapy
- Psychotherapy
- Behavioral Disciplines and Activities
- Health Care Economics and Organizations
- Cognitive Behavioral Therapy
- Health Planning
- Health Resources
- Mindfulness
Other Study ID Numbers
- 2023-0363
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
De-identified data may be placed in one or more electronic databases which could be used for other research studies
IPD Sharing Time Frame
Data sharing will generally coincide with publication of the study's main findings and is intended to take place within 1 year after acceptance of the primary manuscripts.
IPD Sharing Access Criteria
To be determined
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
Massachusetts General HospitalRecruitingDepression | Depression - Major Depressive Disorder | Depression Chronic | Depression in Adults | Depression Disorders | Depression DisorderUnited States
-
University of California, San FranciscoNational Center for Complementary and Integrative Health (NCCIH)Active, not recruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
ProgenaBiomeWithdrawnDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Sorlandet Hospital HFUniversity of Oslo; Karolinska Institutet; Australian Catholic University; Helse...RecruitingAnxiety | Anxiety Depression | Depression Anxiety Disorder | Depression - Major Depressive DisorderNorway
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
Lipocine Inc.CompletedDepression, Postpartum | Postnatal Depression | Peripartum Depression | Depression, Post-Partum | Postpartum Depression (PPD) | Post-Natal DepressionUnited States
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Vituity PsychiatryActive, not recruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Kolby Walker, DO; Brittany KimbleRecruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
University of CincinnatiNational Center for Complementary and Integrative Health (NCCIH)RecruitingMild DepressionUnited States
-
Fondation FondaMentalGYNOVNot yet recruitingDepression | Depression in Adults | Depression DisorderFrance
Clinical Trials on Action In Mindfulness (AIM)+
-
University of Sao PauloAssociação Fundo de Incentivo à PesquisaCompleted
-
Universidad de los Andes, ChileRecruiting
-
Shaare Zedek Medical CenterRecruiting
-
University of JaénCompletedOro-Facial-Digital SyndromeSpain
-
Ege UniversityCompleted
-
Akdeniz UniversityActive, not recruiting
-
University of California, Los AngelesBodiMojo, Inc.CompletedChronic Pain | Parents | Pediatric DisorderUnited States
-
Virginia Commonwealth UniversityAmerican Psychological Association (APA)Completed